Vestal Point Capital, LP
CIK 1974915 · Lihat di SEC EDGAR ↗
- Nilai Portofolio
- $4.3B
- Posisi
- 68
- Per tanggal
- 30 Juni 2026
#897 dari 9.443 berdasarkan nilai 13F · top 9.5%
Nilai portofolio QoQ: +19.6% 13F tidak mengungkapkan kas
- Bobot 10 kepemilikan teratas
- 50,29%
- Bobot 25 kepemilikan teratas
- 80,28%
- Posisi di atas 1%
- 29
- Jumlah posisi efektif
- 27,4
Berdasarkan kepemilikan ekuitas jangka panjang 13F saja (kas, obligasi, posisi jual tidak diungkapkan)
Perputaran Q2 2026: 39,4% Perkiraan pembelian $1.600.614.478 · penjualan $1.547.505.051
Kepemilikan median: 2,5 kuartal Dilacak Q4 2024–Q2 2026 · 37,8% masih dipegang
- Posisi baru
- 11
- Meningkat
- 31
- Menurun
- 21
- Tertutup
- 33
Di halaman ini
- Kinerja vs S&P Bagaimana portofolio 13F manajer ini berkinerja terhadap S&P 500.
- Rincian sektor Bagaimana portofolio terbagi di berbagai sektor pasar.
- Portofolio Setiap saham yang dilaporkan dimiliki oleh institusi ini, dari 13F terbarunya.
- Taruhan Bernilai Tinggi Kepemilikan yang paling terkonsentrasi pada manajer ini.
- Taruhan baru terbesar Posisi baru yang dibuka pada kuartal terakhir.
- Pergerakan Teratas Peningkatan dan penurunan posisi terbesar pada kuartal ini.
- Posisi yang keluar Posisi yang sepenuhnya dijual oleh manajer pada kuartal lalu.
Kinerja vs S&P 500
Tahunan: +68.0% · S&P 500: +18.0%
Perkiraan portofolio beli-dan-tahan yang dibangun dari snapshot 13F SEC triwulanan. Mengecualikan kas, posisi jual, opsi/derivatif, dan sekuritas non-13(f) — mencerminkan buku ekuitas long yang diungkapkan saja, bukan total AUM dana. Keterlambatan pengajuan SEC hingga 45 hari; ini bukan waktu yang dapat disalin secara real-time.
Cakupan yang dapat dihargai: 98,8% · Opsi dikecualikan: 1,6%
Rincian sektor
Healthcare
96,5%
Lainnya/Tidak terpetakan
3,5%
Portofolio lengkap 68 posisi
| Tipe | Rentetan | Tren 8 kuartal | |||||
|---|---|---|---|---|---|---|---|
| BMRN BioMarin Pharmaceutical Inc. - Common Stock | $344.750.500 | 8,06% | 6.025.000 | $142.798.750 | Naik ×4 | ||
| NBIX Neurocrine Biosciences, Inc. - Common Stock | $316.845.800 | 7,40% | 1.880.000 | $152.170.800 | Naik ×1 | ||
| ABVX Abivax SA - American Depositary Shares | $313.086.774 | 7,32% | 2.349.443 | $146.061.774 | Naik ×1 | ||
| UTHR United Therapeutics Corporation - Common Stock | $235.696.050 | 5,51% | 435.000 | $191.222.550 | Naik ×1 | ||
| ELVN Enliven Therapeutics, Inc. - Common Stock | $203.000.000 | 4,74% | 4.000.000 | $75.600.000 | Naik ×1 | ||
| NRIX Nurix Therapeutics, Inc. - Common stock | $195.293.000 | 4,56% | 8.050.000 | $94.543.000 | Naik ×6 | ||
| BCAX Bicara Therapeutics Inc. - Common Stock | $155.872.500 | 3,64% | 5.250.000 | $47.969.250 | Turun ×1 | ||
| TSHA Taysha Gene Therapies, Inc. - Common Stock | $132.216.150 | 3,09% | 19.415.000 | $51.756.150 | Naik ×4 | ||
| ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | $128.378.250 | 3,00% | 1.575.000 | $-14.264.250 | Turun ×1 | ||
| ABT Abbott Laboratories Common Stock | $127.036.000 | 2,97% | 1.400.000 | ||||
| ZBH Zimmer Biomet Holdings, Inc. Common Stock | $120.526.000 | 2,82% | 1.400.000 | $103.346.200 | Naik ×2 | ||
| IRON Disc Medicine, Inc. - Common Stock | $113.367.000 | 2,65% | 1.550.000 | $68.609.000 | Naik ×1 | ||
| GLUE Monte Rosa Therapeutics, Inc. - Common Stock | $111.320.000 | 2,60% | 4.600.000 | $52.043.001 | Naik ×2 | ||
| PODD Insulet Corporation - Common Stock | $102.007.500 | 2,38% | 670.000 | $91.389.386 | Naik ×1 | ||
| Penerbit tidak dikenal (CUSIP: K08588103) | $100.020.000 | 2,34% | 375.000 | Naik ×1 | |||
| AZN AstraZeneca PLC - American Depositary Shares | $85.329.000 | 1,99% | 450.000 | $65.607.000 | Naik ×1 | ||
| SNY Sanofi - American Depositary Shares | $85.320.000 | 1,99% | 2.000.000 | $17.868.000 | Naik ×1 | ||
| RVMD Revolution Medicines, Inc. - Common Stock | $84.276.000 | 1,97% | 450.000 | $-146.692.750 | Turun ×1 | ||
| BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | $83.000.000 | 1,94% | 8.300.000 | $16.122.000 | Naik ×2 | ||
| DYN Dyne Therapeutics, Inc. - Common Stock | $74.958.750 | 1,75% | 3.375.000 | $2.438.750 | Turun ×1 | ||
| NKTR Nektar Therapeutics - Common Stock | $69.810.000 | 1,63% | 1.000.000 | $49.304.250 | Naik ×1 | ||
| GMED Globus Medical, Inc. Class A Common Stock | $67.158.500 | 1,57% | 850.000 | $14.556.097 | Naik ×1 | ||
| TARS Tarsus Pharmaceuticals, Inc. - Common Stock | $66.087.000 | 1,54% | 1.050.000 | $52.057.000 | Naik ×1 | ||
| IMTX Immatics N.V. - Ordinary Shares | $62.552.750 | 1,46% | 6.175.000 | $1.790.750 | |||
| TRVI Trevi Therapeutics, Inc. - Common Stock | $57.815.000 | 1,35% | 3.100.000 | $31.968.607 | Naik ×1 | ||
| IMCR Immunocore Holdings plc - American Depositary Shares | $57.150.000 | 1,34% | 1.800.000 | $-26.271.070 | Turun ×1 | ||
| RGEN Repligen Corporation - Common Stock | $54.576.000 | 1,28% | 400.000 | $-54.407.500 | Turun ×1 | ||
| BMY Bristol-Myers Squibb Company Common Stock | $46.096.000 | 1,08% | 800.000 | $-14.554.000 | Turun ×1 | ||
| QURE uniQure N.V. - Ordinary Shares | $43.066.100 | 1,01% | 935.000 | $37.196.515 | Naik ×1 | ||
| XENE Xenon Pharmaceuticals Inc. - Common Shares | $42.252.000 | 0,99% | 700.000 | $5.041.815 | Naik ×2 | ||
| DRUG Bright Minds Biosciences Inc. - common stock | $38.259.000 | 0,89% | 545.000 | $2.334.483 | Naik ×1 | ||
| MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | $34.901.750 | 0,82% | 65.000 | $18.429.196 | Naik ×1 | ||
| ALC Alcon Inc. Ordinary Shares | $33.550.000 | 0,78% | 500.000 | $-26.730.000 | Turun ×2 | ||
| MYGN Myriad Genetics, Inc. - Common Stock | $32.746.850 | 0,77% | 5.735.000 | $25.330.850 | Naik ×3 | ||
| RAPP Rapport Therapeutics, Inc. - Common Stock | $30.419.100 | 0,71% | 730.000 | $-14.520.505 | Turun ×1 | ||
| CBIO Crescent Biopharma, Inc. - Common Stock | $29.340.000 | 0,69% | 1.630.000 | $1.785.000 | Naik ×1 | ||
| GEHC GE HealthCare Technologies Inc. - Common Stock | $28.804.500 | 0,67% | 450.000 | $11.009.500 | Naik ×1 | ||
| INSM Insmed Incorporated - Common Stock | $26.655.000 | 0,62% | 250.000 | ||||
| VKTX Viking Therapeutics, Inc. - Common Stock | $26.526.800 | 0,62% | 680.000 | $-3.219.543 | Turun ×1 | ||
| BBNX Beta Bionics, Inc. - Common Stock | $25.072.000 | 0,59% | 1.600.000 | $2.912.590 | Turun ×1 | ||
| REGN Regeneron Pharmaceuticals, Inc. - Common Stock | $24.941.600 | 0,58% | 40.000 | $-5.964.000 | |||
| SLDB Solid Biosciences Inc. - Common Stock | $21.578.400 | 0,50% | 2.160.000 | $-14.421.600 | Turun ×2 | ||
| ANRO Alto Neuroscience, Inc. Common Stock | $20.716.150 | 0,48% | 785.000 | $-25.684.256 | Turun ×2 | ||
| Penerbit tidak dikenal (CUSIP: 337185102) | $20.381.560 | 0,48% | 1.013.000 | Naik ×1 | |||
| LXEO Lexeo Therapeutics, Inc. - Common Stock | $20.109.600 | 0,47% | 4.320.000 | $-5.576.900 | Turun ×1 | ||
| SVRA Savara, Inc. - Common Stock | $16.755.200 | 0,39% | 2.720.000 | $2.558.916 | Naik ×2 | ||
| GLTO Galecto, Inc. - Common Stock | $14.955.750 | 0,35% | 575.000 | $-584.250 | Turun ×1 | ||
| SGP SpyGlass Pharma, Inc. - Common Stock | $14.914.200 | 0,35% | 670.000 | $-2.361.552 | Naik ×1 | ||
| TECX Tectonic Therapeutic, Inc. - Common Stock | $14.609.375 | 0,34% | 425.000 | $4.470.895 | Naik ×1 | ||
| AVTX Avalo Therapeutics, Inc. - Common Stock | $14.322.000 | 0,33% | 775.000 | Naik ×1 | |||
| EVMN Evommune, Inc. Common Stock | $13.290.000 | 0,31% | 1.000.000 | Naik ×1 | |||
| Penerbit tidak dikenal (CUSIP: 482931102) | $12.667.250 | 0,30% | 575.000 | Naik ×1 | |||
| AVR Anteris Technologies Global Corp. - Common Stock | $9.948.500 | 0,23% | 1.010.000 | $3.594.971 | Turun ×1 | ||
| ZBIO Zenas BioPharma, Inc. - Common Stock | $9.263.700 | 0,22% | 365.000 | $5.353.700 | Naik ×1 | ||
| VYGR Voyager Therapeutics, Inc. - Common Stock | $9.187.500 | 0,21% | 2.625.000 | $-2.403.833 | Turun ×1 | ||
| OKUR OnKure Therapeutics, Inc. - Class A Common Stock | $8.325.187 | 0,19% | 1.825.699 | $708.336 | Turun ×1 | ||
| SRZN Surrozen, Inc. - Common Stock | $7.906.161 | 0,18% | 304.669 | $-1.957.577 | Turun ×1 | ||
| MNPR Monopar Therapeutics Inc. - Common Stock | $7.011.563 | 0,16% | 75.727 | $3.427.311 | Naik ×1 | ||
| ZURA Zura Bio Limited - Class A Ordinary shares | $6.926.340 | 0,16% | 1.173.956 | $3.885.890 | Naik ×1 | ||
| OLMA Olema Pharmaceuticals, Inc. - Common Stock | $5.236.073 | 0,12% | 418.551 | $-1.153.622 | Turun ×2 | ||
| PALI Palisade Bio, Inc. - Common Stock | $5.225.000 | 0,12% | 2.500.000 | $850.000 | |||
| IBIO iBio, Inc. - Common Stock | $4.550.000 | 0,11% | 2.600.000 | Naik ×1 | |||
| SGMT Sagimet Biosciences Inc. - Series A Common Stock | $4.139.044 | 0,10% | 535.452 | Naik ×1 | |||
| Penerbit tidak dikenal (CUSIP: 29286X101) | $2.884.654 | 0,07% | 1.667.430 | Naik ×1 | |||
| RZLT Rezolute, Inc. - Common Stock (NV) | $1.991.595 | 0,05% | 382.999 | ||||
| NYXH Nyxoah SA - Ordinary Shares | $1.425.449 | 0,03% | 843.461 | $-1.111.041 | Turun ×6 | ||
| TENX Tenax Therapeutics, Inc. - Common Stock | $777.537 | 0,02% | 53.439 | $-76.953 | |||
| APRE Aprea Therapeutics, Inc. - Common Stock | $280.805 | 0,01% | 350.000 | $13.790 | |||
| Tidak ada hasil | |||||||
Kepemilikan dengan keyakinan
Posisi meningkat selama 3+ kuartal berturut-turut.
Jumlah saham dilaporkan dalam pengajuan 13F (tidak disesuaikan split)
Taruhan baru terbesar
Posisi baru dibuka kuartal ini, terbesar diurutkan pertama.
| Sekuritas | Nilai | Saham | % dari portofolio |
|---|---|---|---|
| ABT | $127.036.000 | 1.400.000 | 2,97% |
| Penerbit tidak dikenal (CUSIP: K08588103) | $100.020.000 | 375.000 | 2,34% |
| INSM | $26.655.000 | 250.000 | 0,62% |
| Penerbit tidak dikenal (CUSIP: 337185102) | $20.381.560 | 1.013.000 | 0,48% |
| AVTX | $14.322.000 | 775.000 | 0,33% |
| EVMN | $13.290.000 | 1.000.000 | 0,31% |
| Penerbit tidak dikenal (CUSIP: 482931102) | $12.667.250 | 575.000 | 0,30% |
| IBIO | $4.550.000 | 2.600.000 | 0,11% |
| SGMT | $4.139.044 | 535.452 | 0,10% |
| Penerbit tidak dikenal (CUSIP: 29286X101) | $2.884.654 | 1.667.430 | 0,07% |
| RZLT | $1.991.595 | 382.999 | 0,05% |
Penggerak teratas (QoQ)
| Sekuritas | Aksi | Saham Δ | Nilai Δ |
|---|---|---|---|
| NBIX | Beli lebih banyak | +630K | +$152.2M |
| RVMD | Dipangkas | -1.9M | -$146.7M |
| ABVX | Beli lebih banyak | +849K | +$146.1M |
| BMRN | Beli lebih banyak | +2.5M | +$142.8M |
| NRIX | Beli lebih banyak | +1.6M | +$94.5M |
| ELVN | Beli lebih banyak | +750K | +$75.6M |
| IRON | Beli lebih banyak | +850K | +$68.6M |
| AZN | Beli lebih banyak | +350K | +$65.6M |
| RGEN | Dipangkas | -525K | -$54.4M |
| TARS | Beli lebih banyak | +850K | +$52.1M |
3 posisi disembunyikan (pemeriksaan kelengkapan data)
Posisi yang keluar
Termasuk peristiwa perusahaan (merger, delisting) — tidak semua keluar adalah penjualan
Posisi tertutup mencerminkan perubahan pelaporan 13F; bagi manajer indeks, ini sering kali mekanis (penghapusan pencatatan, M&A, penyeimbangan ulang indeks), bukan keputusan aktif.
| Sekuritas | Kuartal | Saham sebelumnya | Nilai sebelumnya | Harga sejak keluar |
|---|---|---|---|---|
| QQQ | 31 Maret 2026 | 350.000 | $215.008.500 | |
| ACLX | 31 Maret 2026 | 2.925.000 | $190.710.000 | Tidak lagi dilacak |
| JAZZ | 31 Maret 2025 | 975.000 | $120.071.250 | 101,7% |
| APGE | 30 Juni 2026 | 1.100.000 | $92.587.000 | 1,6% |
| ASND | 30 Juni 2026 | 375.000 | $85.773.750 | -3,3% |
| DXCM | 31 Maret 2026 | 1.275.000 | $84.621.750 | 42,4% |
| INSM | 30 Juni 2025 | 1.075.000 | $82.011.750 | 24,6% |
| MRK | 31 Maret 2026 | 775.000 | $81.576.500 | 26,1% |
| MRK | 31 Maret 2025 | 800.000 | $79.584.000 | 69,0% |
| FOLD | 31 Des. 2025 | 9.750.000 | $76.830.000 | Tidak lagi dilacak |
| ABT | 31 Maret 2026 | 600.000 | $75.174.000 | 11,4% |
| IONS | 31 Des. 2025 | 1.075.000 | $70.326.500 | -24,3% |
| SRRK | 30 Juni 2026 | 1.324.422 | $65.108.586 | 0,2% |
| BDX | 31 Des. 2025 | 325.000 | $60.830.250 | 23,7% |
| BMRN | 31 Maret 2025 | 860.000 | $56.527.800 | -4,3% |
| VERA | 30 Juni 2026 | 1.368.159 | $55.041.037 | -26,2% |
| TERN | 30 Juni 2026 | 1.000.000 | $52.720.000 | Tidak lagi dilacak |
| GEHC | 30 Sep. 2025 | 700.000 | $51.849.000 | -1,4% |
| BSX | 30 Juni 2026 | 800.000 | $50.200.000 | 15,8% |
| NUVL | 30 Juni 2026 | 481.715 | $49.351.702 | Tidak lagi dilacak |
| JAZZ | 31 Maret 2026 | 290.000 | $49.300.000 | 32,4% |
| DAWN | 31 Maret 2026 | 5.200.000 | $48.464.000 | Tidak lagi dilacak |
| SLNO | 31 Maret 2025 | 1.060.000 | $47.647.000 | Tidak lagi dilacak |
| COGT | 30 Juni 2026 | 1.230.888 | $47.376.879 | -6,6% |
| DNTH | 31 Des. 2025 | 1.180.000 | $46.433.000 | 171,3% |
| CYTK | 31 Des. 2025 | 725.000 | $39.846.000 | 21,9% |
| CLDX | 30 Juni 2026 | 1.224.165 | $38.830.514 | 9,1% |
| BIIB | 31 Des. 2025 | 275.000 | $38.522.000 | 22,5% |
| AXSM | 31 Maret 2026 | 210.000 | $38.354.400 | 23,4% |
| CDTX | 31 Des. 2025 | 400.000 | $38.304.000 | Tidak lagi dilacak |
| KALV | 30 Juni 2026 | 1.850.000 | $37.240.500 | Tidak lagi dilacak |
| SNY | 31 Maret 2025 | 750.000 | $36.172.500 | -17,7% |
| ATXS | 31 Des. 2025 | 4.956.000 | $36.079.680 | Tidak lagi dilacak |
| PTGX | 30 Juni 2026 | 326.159 | $34.377.159 | 23,9% |
| DNLI | 30 Juni 2026 | 1.773.326 | $34.047.859 | -2,2% |
| GSK | 31 Maret 2025 | 1.000.000 | $33.820.000 | 33,6% |
| CRNX | 31 Des. 2025 | 750.000 | $31.237.500 | 82,1% |
| AZN | 31 Maret 2025 | 475.000 | $31.122.000 | 125,2% |
| WAT | 30 Juni 2026 | 100.000 | $29.780.000 | 6,1% |
| DHR | 31 Des. 2025 | 150.000 | $29.739.000 | -6,5% |
| MDGL | 31 Maret 2025 | 95.000 | $29.314.150 | 56,7% |
| INSP | 30 Juni 2026 | 539.269 | $27.815.495 | 36,1% |
| MLTX | 30 Sep. 2025 | 550.000 | $25.960.000 | 121,2% |
| COO | 30 Sep. 2025 | 350.000 | $24.906.000 | 10,5% |
| GPCR | 30 Sep. 2025 | 1.200.000 | $24.888.000 | 81,6% |
| SLNO | 30 Juni 2026 | 730.000 | $24.440.400 | Tidak lagi dilacak |
| LNTH | 31 Maret 2026 | 360.000 | $23.958.000 | 32,2% |
| URGN | 30 Juni 2025 | 2.152.957 | $23.811.704 | 237,6% |
| EW | 30 Sep. 2025 | 300.000 | $23.463.000 | 14,9% |
| BLTE | 31 Des. 2025 | 312.500 | $23.125.000 | 2,5% |
| ZYME | 31 Maret 2026 | 865.000 | $22.775.450 | 8,0% |
| RARE | 31 Des. 2025 | 750.000 | $22.560.000 | 13,6% |
| COGT | 30 Sep. 2025 | 3.080.000 | $22.114.400 | 151,7% |
| IONS | 31 Maret 2025 | 595.000 | $20.801.200 | 98,5% |
| CYTK | 30 Juni 2026 | 300.000 | $19.773.000 | -9,1% |
| UPB | 31 Maret 2026 | 720.000 | $19.548.000 | -22,7% |
| WST | 30 Juni 2026 | 75.000 | $18.798.000 | -1,7% |
| RARE | 30 Juni 2025 | 500.000 | $18.105.000 | -28,2% |
| LQDA | 30 Juni 2025 | 1.227.403 | $18.104.194 | 462,0% |
| ESTA | 30 Juni 2025 | 433.193 | $17.676.440 | 67,2% |
| MDT | 30 Sep. 2025 | 195.000 | $16.998.150 | -3,3% |
| VRNA | 30 Juni 2025 | 267.627 | $16.991.638 | Tidak lagi dilacak |
| PRGO | 30 Sep. 2025 | 625.000 | $16.700.000 | -38,0% |
| WGS | 30 Juni 2026 | 250.000 | $16.055.000 | 18,5% |
| PEN | 31 Maret 2026 | 50.000 | $15.545.500 | -1,3% |
| LEGN | 31 Maret 2025 | 475.000 | $15.456.500 | -35,8% |
| AGIO | 30 Juni 2026 | 450.000 | $15.223.500 | -8,9% |
| ROIV | 31 Maret 2025 | 1.250.000 | $14.787.500 | 266,8% |
| ENGN | 30 Juni 2026 | 2.165.000 | $14.743.650 | 3,8% |
| BRKR | 31 Des. 2025 | 440.000 | $14.295.600 | 25,1% |
| REGN | 31 Maret 2025 | 20.000 | $14.246.600 | 32,1% |
| REGN | 31 Des. 2025 | 25.000 | $14.056.750 | 8,5% |
| QURE | 31 Des. 2025 | 225.000 | $13.133.250 | 106,6% |
| SRPT | 30 Juni 2025 | 200.000 | $12.764.000 | 14,4% |
| BHVN | 31 Des. 2025 | 701.700 | $10.532.517 | 26,3% |
| TMO | 30 Sep. 2025 | 25.000 | $10.136.500 | 27,9% |
| A | 31 Maret 2025 | 75.000 | $10.075.500 | 33,7% |
| INSP | 31 Des. 2025 | 135.000 | $10.017.000 | -34,2% |
| ARVN | 30 Juni 2026 | 905.465 | $9.597.929 | 9,9% |
| APLT | 31 Des. 2025 | 14.250.000 | $8.619.825 | Tidak lagi dilacak |
| MPLT | 30 Juni 2026 | 420.000 | $8.538.600 | -68,7% |
| MNMD | 31 Maret 2026 | 637.000 | $8.529.430 | Tidak lagi dilacak |
| FULC | 30 Juni 2026 | 1.100.000 | $8.437.000 | 6,0% |
| ZLAB | 31 Maret 2025 | 300.000 | $7.857.000 | -28,0% |
| CGON | 31 Des. 2025 | 175.000 | $7.049.000 | 88,5% |
| TVRD | 31 Des. 2025 | 167.000 | $6.507.990 | -56,9% |
| VTYX | 31 Des. 2025 | 2.050.000 | $6.375.500 | Tidak lagi dilacak |
| GILD | 31 Maret 2026 | 50.000 | $6.137.000 | 3,9% |
| NTLA | 31 Maret 2025 | 525.000 | $6.121.500 | 79,0% |
| IMVT | 30 Juni 2025 | 350.000 | $5.981.500 | 178,4% |
| DBVT | 31 Maret 2026 | 300.000 | $5.751.000 | -30,5% |
| CADL | 30 Juni 2026 | 1.125.000 | $5.512.500 | 23,4% |
| GSK | 31 Des. 2025 | 125.000 | $5.395.000 | 5,5% |
| ITOS | 30 Juni 2025 | 900.000 | $5.373.000 | Tidak lagi dilacak |
| TVTX | 30 Sep. 2025 | 355.000 | $5.254.000 | 171,9% |
| MIRM | 31 Maret 2026 | 66.000 | $5.213.340 | 5,4% |
| GLPG | 30 Juni 2025 | 200.000 | $5.024.000 | Tidak lagi dilacak |
| CMRX | 31 Maret 2025 | 1.400.000 | $4.872.000 | Tidak lagi dilacak |
| ZBH | 30 Sep. 2025 | 50.000 | $4.560.500 | 0,9% |
| LENZ | 31 Maret 2026 | 275.000 | $4.400.000 | -47,8% |
| VCYT | 30 Juni 2026 | 130.687 | $4.209.428 | -29,5% |
| EXAS | 31 Des. 2025 | 75.000 | $4.103.250 | Tidak lagi dilacak |
| ESTA | 31 Des. 2025 | 100.000 | $4.099.000 | -2,0% |
| KOD | 31 Des. 2025 | 250.000 | $4.092.500 | 43,5% |
| RZLT | 31 Maret 2026 | 1.686.000 | $3.978.960 | 60,8% |
| GERN | 30 Juni 2026 | 2.540.000 | $3.784.600 | 21,5% |
| KNSA | 30 Juni 2025 | 169.864 | $3.772.679 | 181,9% |
| NBIX | 30 Sep. 2025 | 30.000 | $3.770.700 | 9,7% |
| ARQT | 31 Des. 2025 | 200.000 | $3.770.000 | -13,5% |
| VERV | 31 Maret 2025 | 645.000 | $3.637.800 | Tidak lagi dilacak |
| RCUS | 31 Des. 2025 | 250.000 | $3.400.000 | 26,2% |
| ALLO | 31 Maret 2025 | 1.500.000 | $3.195.000 | 44,9% |
| TMDX | 31 Maret 2025 | 50.000 | $3.117.500 | 37,0% |
| GLUE | 31 Maret 2025 | 425.000 | $2.949.500 | 221,4% |
| STRO | 31 Maret 2026 | 243.000 | $2.811.510 | -12,6% |
| NVCR | 30 Juni 2026 | 250.000 | $2.725.000 | 14,9% |
| URGN | 30 Juni 2026 | 139.079 | $2.500.640 | 25,7% |
| GPCR | 31 Maret 2026 | 35.000 | $2.434.250 | 5,5% |
| PASG | 30 Juni 2026 | 305.000 | $2.394.250 | -3,7% |
| ARCT | 30 Juni 2025 | 211.790 | $2.242.856 | -9,8% |
| BDTX | 31 Maret 2026 | 870.000 | $2.114.100 | 5,9% |
| TYRA | 30 Juni 2026 | 54.000 | $2.068.200 | -17,4% |
| BHC | 31 Maret 2025 | 250.000 | $2.015.000 | 4,9% |
| NGNE | 31 Maret 2025 | 80.000 | $1.828.800 | 228,3% |
| ACHL | 31 Maret 2025 | 1.500.000 | $1.710.000 | Tidak lagi dilacak |
| FATE | 31 Maret 2026 | 1.725.000 | $1.694.985 | 108,0% |
| VRDN | 30 Sep. 2025 | 100.000 | $1.398.000 | 14,1% |
| LUNG | 31 Des. 2025 | 830.000 | $1.344.600 | 6,3% |
| ALEC | 31 Maret 2026 | 755.000 | $1.177.800 | 5,8% |
| RGNX | 30 Juni 2026 | 108.525 | $909.440 | -8,3% |
| MGNX | 30 Juni 2026 | 280.000 | $809.200 | -9,6% |
| ATRA | 30 Sep. 2025 | 94.085 | $726.336 | -35,3% |
| ABSI | 30 Juni 2026 | 232.219 | $696.657 | -17,5% |
| TRAW | 31 Des. 2025 | 150.000 | $277.500 | -53,9% |
| CNTA | 30 Juni 2025 | 14.888 | $214.089 | Tidak lagi dilacak |